Eli Lilly and Company Selects I-Many's Life Sciences Enterprise Contract Management Suite

Business Wire, Nov 1, 2004

EDISON, N.J. -- I-many, Inc. (NASDAQ:IMNY), the leader in enterprise contract management solutions, announced today that Eli Lilly and Company (NYSE:LLY), a global pharmaceutical company, has selected I-many's Life Sciences Enterprise Contract Management Suite. With the selection and on-going implementation project, Lilly joins the ranks of the top 20 pharmaceutical manufacturers who have chosen I-many for contract management solutions.

I-many's solutions help pharmaceutical companies manage all commercial agreements with institutional and managed care customers, as well as all government-mandated programs such as Medicaid. I-many's industry-leading Government Pricing product helps pharmaceutical companies maintain compliance with government pricing regulations. It is currently being used by several of the largest pharmaceutical companies to calculate and submit key pricing information to the government.

I-many's solutions help pharmaceutical manufacturers manage the full contract continuum from pre-contract phases to contract creation, approval and storage, and contract administration compliance and optimization:

--I-many CARS(R): The gold standard of contract management solutions. Provides comprehensive, end-to-end management of mission critical, incentive-driven contract and program processes.

--I-many Government Pricing(TM): Enables companies to quickly and efficiently monitor and comply with all government-mandated pricing and reporting requirements established by the Medicaid Drug Rebate Program, the Federal Supply Schedule and the Veteran's Health Care Act of 1992.

--I-many Medicaid(TM): Processes data, calculates rebates and creates payments for both federal and state rebate programs.

--I-many State Supplemental(TM): Streamlines product contract setup and invoice processing. Key components include a Non-Standard Rebate Per Unit Calculator Pack and Supplemental Claim Processing.

--I-many Contract Manager(TM): Centralizes contracts in a web-based repository for instantaneous search and view capabilities. Also provides the ability to create contracts from existing templates and clauses.

--I-many Reporting(TM): Enables companies to analyze their contracts and improve their contracting processes by aggregating contract data by type, size, industry and other criteria.

"I-many continues to grow its installed base of global pharmaceutical companies by consistently adding value in the area of enterprise contract management. We have expanded our service offerings, deepened our life sciences domain expertise, and introduced new products that automate key contract management functions and ensure compliance", said Leigh Powell, president and chief executive officer of I-many "We are extremely pleased Lilly selected I-many's Life Sciences Enterprise Contract Management Suite of products and are enjoying working in partnership with them throughout this strategic deployment to optimize and maximize their operations."

About I-many

I-many (NASDAQ:IMNY) delivers advanced business solutions for managing corporate commitments. I-many solution suites comprehensively manage any type of commitment from contracts and obligations to payments and collections, maximizing revenue and delivering hard cost savings. For more information, visit the company at www.imany.com.

This press release may contain forward-looking statements relating to the future performance of I-many, Inc. Forward-looking statements, specifically those concerning future performance, are subject to certain risks and uncertainties, and actual results may differ materially from expectations.

All trademarks are the property of their respective owners.